Jason R Kelly Ginkgo Bioworks Holdings, Inc. (DNA) insider trading activity

Jason R Kelly is Director of Ginkgo Bioworks Holdings, Inc.. Currently has a direct ownership of 3.89 Million shares of DNA, which is worth approximately $24.3 Million. The most recent transaction as insider was on Apr 12, 2023, when has been sold 100,000 shares (Class A Common Stock) at a price of $1.31 per share, resulting in proceeds of $131,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.89M

0% 3M change

43.51% 12M change

Total Value Held $24.3 Million

Jason R Kelly Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 12 2023	SELL Open market or private sale	$131,000 $1.31 p/Share	100,000 Reduced 0.87%	11,394,680 Class A Common Stock
Apr 06 2023	SELL Open market or private sale	$131,000 $1.31 p/Share	100,000 Reduced 0.86%	11,494,680 Class A Common Stock
Apr 05 2023	SELL Open market or private sale	$122,000 $1.22 p/Share	100,000 Reduced 0.86%	11,594,680 Class A Common Stock
Mar 30 2023	SELL Open market or private sale	$124,000 $1.24 p/Share	100,000 Reduced 0.85%	11,694,680 Class A Common Stock
Mar 29 2023	SELL Open market or private sale	$124,000 $1.24 p/Share	100,000 Reduced 0.84%	11,794,680 Class A Common Stock
Mar 23 2023	SELL Open market or private sale	$126,000 $1.26 p/Share	100,000 Reduced 0.83%	11,894,680 Class A Common Stock
Mar 22 2023	SELL Open market or private sale	$128,000 $1.28 p/Share	100,000 Reduced 0.83%	11,994,680 Class A Common Stock
Mar 16 2023	SELL Open market or private sale	$131,000 $1.31 p/Share	100,000 Reduced 0.82%	12,094,680 Class A Common Stock
Mar 15 2023	SELL Open market or private sale	$132,000 $1.32 p/Share	100,000 Reduced 0.81%	12,194,680 Class A Common Stock
Mar 14 2023	SELL Open market or private sale	$399,000 $1.33 p/Share	300,000 Reduced 2.38%	12,294,680 Class A Common Stock
Mar 01 2023	SELL Open market or private sale	$139,000 $1.39 p/Share	100,000 Reduced 0.79%	12,594,680 Class A Common Stock
Feb 23 2023	SELL Open market or private sale	$160,000 $1.6 p/Share	100,000 Reduced 0.78%	12,694,680 Class A Common Stock
Feb 22 2023	SELL Open market or private sale	$165,000 $1.65 p/Share	100,000 Reduced 0.78%	12,794,680 Class A Common Stock
Feb 16 2023	SELL Open market or private sale	$177,000 $1.77 p/Share	100,000 Reduced 0.77%	12,894,680 Class A Common Stock
Feb 15 2023	SELL Open market or private sale	$179,000 $1.79 p/Share	100,000 Reduced 0.76%	12,994,680 Class A Common Stock
Feb 09 2023	SELL Open market or private sale	$181,000 $1.81 p/Share	100,000 Reduced 0.76%	13,094,680 Class A Common Stock
Feb 08 2023	SELL Open market or private sale	$430,264 $1.88 p/Share	228,864 Reduced 1.7%	13,194,680 Class A Common Stock
Feb 07 2023	SELL Open market or private sale	$297,467 $1.96 p/Share	151,769 Reduced 1.12%	13,423,544 Class A Common Stock
Feb 06 2023	SELL Open market or private sale	$312,424 $1.98 p/Share	157,790 Reduced 1.15%	13,575,313 Class A Common Stock
Feb 03 2023	SELL Open market or private sale	$333,095 $2.13 p/Share	156,383 Reduced 1.13%	13,733,103 Class A Common Stock
Feb 02 2023	SELL Open market or private sale	$217,000 $2.17 p/Share	100,000 Reduced 0.71%	13,889,486 Class A Common Stock
Feb 01 2023	SELL Open market or private sale	$489,427 $1.92 p/Share	254,910 Reduced 1.79%	13,989,486 Class A Common Stock
Jan 31 2023	SELL Open market or private sale	$276,674 $1.85 p/Share	149,554 Reduced 1.04%	14,244,396 Class A Common Stock
Jan 30 2023	SELL Open market or private sale	$294,862 $1.89 p/Share	156,012 Reduced 1.07%	14,393,950 Class A Common Stock
Jan 27 2023	SELL Open market or private sale	$265,550 $1.82 p/Share	145,907 Reduced 0.99%	14,549,962 Class A Common Stock

JRK

Jason R Kelly

Director

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNA shares.

Notify only if

Value

Insider Trading

Get notified when an Ginkgo Bioworks Holdings, Inc. insider buys or sells DNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Ginkgo Bioworks Holdings, Inc.

Track Activities on DNA

Account